View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200 / Paclitaxel 175 / Carboplatin 5 - Pembrolizumab 400, Endometrial Cancer, Cycle 7-20
Protocol-ID: 2316 V1.0 (Mini), PEMB200/PACL175/CRBP5 - PEMB400, Endometrial Ca, C7-20Indication(s)
- Endometrial Cancer; ICD-10 C54.1
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 08.04.2023